References
- ShinHRBoniolMJoubertCSecular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and TaiwanCancer Sci20101011141124620367639
- PerezEACurrent management of metastatic breast cancerSemin Oncol19992611010482189
- KawaguchiTIwaseSTakeuchiHChemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case reportCases J200924908120062718
- HortobagyiGNTreatment of breast cancerN Engl J Med19983399749849753714
- TsaoMNLloydNWongRKWhole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesCochrane Database Syst Rev20124CD00386922513917
- CroomKFDhillonSBevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancerDrugs2011712213222922035518
- GordonMSMargolinKTalpazMPhase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancerJ Clin Oncol20011984385011157038
- FriedmanHSPradosMDWenPYBevacizumab alone and in combination with irinotecan in recurrent glioblastomaJ Clin Oncol2009274733474019720927
- AghaCAIbrahimSHassanAEliasDAFathallah-ShaykhHMBevacizumab is active as a single agent against recurrent malignant gliomasAnticancer Res20103060961120332478
- SocinskiMALangerCJHuangJESafety of bevacizumab in patients with non-small-cell lung cancer and brain metastasesJ Clin Oncol2009275255526119738122
- BesseBLasserreSFComptonPHuangJAugustusSRohrUPBevacizumab safety in patients with central nervous system metastasesClin Cancer Res20101626927820028762
- LabidiSIBachelotTRay-CoquardIBevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case seriesClin Breast Cancer2009911812119433393
- BhaskaraAEngCBevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastasesClin Colorectal Cancer20087656818279580
- YamamotoDIwaseSYoshidaHEfficacy of meloxicam in combination with preoperative chemotherapy for breast cancer – Japan Breast Cancer Research Network (JBCRN) 02-1 TrialAnticancer Res2011313567357221965779
- De BoerAGGaillardPJStrategies to improve drug delivery across the blood–brain barrierClin Pharmacokinet20074655357617596102
- FerraraNGerberHPLeCouterJThe biology of VEGF and its receptorsNat Med2003966967612778165
- AyIFrancisJWBrownRHVEGF increases blood–brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS miceBrain Res2008123419820518725212
- ZadehGGuhaAMolecular regulators of angiogenesis in the developing nervous system and adult brain tumorsInt J Oncol20032355756512888888
- GerstnerERFineRLIncreased permeability of the blood–brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigmJ Clin Oncol2007252306231217538177
- DietrichWDBustoRHalleyMThe importance of brain temperature in alterations of the blood–brain barrier following cerebral ischemiaJ Neuropathol Exp Neurol1990494864972273405
- ClinicalTrials.govBevacizumab in reducing CNS side effects in patients who have undergone radiation therapy to the brain for primary brain tumor, meningioma, or head and neck cancer Available at: http://clinicaltrials.gov/ct2/results?term=NCT00492089Accessed August 27, 2012
- ClinicalTrials.govA study of bevacizumab in combination with first- or second-line therapy in subjects with brain metastases due to non-squamous NSCLC (PASSPORT) Available at: http://clinicaltrials.gov/ct2/results?term=NCT00312728Accessed August 27, 2012